Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J. Dann, Ron Epelbaum, Rachel Bar‐Shalom et al.|Blood|2006Cited by 124
Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.Simona Ben‐Haim, Dov Front, Rachel Bar‐Shalom et al.|Journal of Clinical Oncology|1996Cited by 51
Primary Lymphoma of Bone – A Retrospective StudyMoshe Stein, Ron Epelbaum, Nissim Haim et al.|Oncology|2003Cited by 40
A 10‐year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preservedEldad J. Dann, Ron Epelbaum, Zeev Blumenfeld et al.|American Journal of Hematology|2011Cited by 34
Gallium-67 scintigraphy in lymphoma with bone involvement.Rachel Bar‐Shalom, Einat Even‐Sapir, Ora Israel et al.|PubMed|1995Cited by 27